HMSD
Basic information
Region (hg38): 18:63949301-63981774
Previous symbols: [ "C18orf53" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HMSD gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 10 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 9 | 1 | 0 |
Variants in HMSD
This is a list of pathogenic ClinVar variants found in the HMSD region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
18-63953476-G-C | not specified | Uncertain significance (Sep 20, 2023) | ||
18-63954442-G-A | not specified | Uncertain significance (Dec 27, 2022) | ||
18-63954451-A-T | not specified | Uncertain significance (Nov 17, 2022) | ||
18-63954457-G-T | not specified | Uncertain significance (Nov 16, 2021) | ||
18-63954463-A-T | not specified | Uncertain significance (Mar 25, 2024) | ||
18-63954466-C-T | not specified | Uncertain significance (Jul 25, 2023) | ||
18-63954477-G-A | not specified | Uncertain significance (Oct 04, 2022) | ||
18-63954493-A-T | not specified | Uncertain significance (Dec 14, 2023) | ||
18-63960194-A-G | not specified | Uncertain significance (Mar 29, 2024) | ||
18-63960198-T-C | not specified | Uncertain significance (Jan 26, 2022) | ||
18-63960199-A-G | not specified | Uncertain significance (Apr 09, 2024) | ||
18-63960243-G-A | not specified | Likely benign (Sep 27, 2022) | ||
18-63960318-G-T | not specified | Uncertain significance (Jun 11, 2021) | ||
18-63978310-T-C | Peeling skin syndrome 5 | Pathogenic (Sep 13, 2016) | ||
18-63978343-C-G | not specified | Uncertain significance (Feb 14, 2023) | ||
18-63978389-C-T | Benign (Oct 07, 2023) | |||
18-63978394-T-C | Benign (Aug 31, 2023) | |||
18-63978438-A-G | not specified | Uncertain significance (Dec 27, 2023) | ||
18-63979829-T-C | not specified | Uncertain significance (Jun 29, 2022) | ||
18-63979835-G-A | Peeling skin syndrome 5 | Benign (Jan 29, 2024) | ||
18-63979886-T-G | Benign (Jan 04, 2024) | |||
18-63979901-AC-A | Peeling skin syndrome 5 | Likely pathogenic (-) | ||
18-63979920-G-C | not specified | Uncertain significance (Jul 28, 2021) | ||
18-63979936-C-T | Likely benign (Dec 15, 2022) | |||
18-63980032-C-T | Benign (May 14, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HMSD | protein_coding | protein_coding | ENST00000408945 | 3 | 32474 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0129 | 0.674 | 124787 | 0 | 3 | 124790 | 0.0000120 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.584 | 60 | 74.2 | 0.809 | 0.00000375 | 919 |
Missense in Polyphen | 15 | 20.225 | 0.74166 | 271 | ||
Synonymous | -0.334 | 27 | 24.9 | 1.08 | 0.00000137 | 254 |
Loss of Function | 0.540 | 3 | 4.19 | 0.715 | 2.44e-7 | 46 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000647 | 0.0000646 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000178 | 0.0000177 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Putative serine protease inhibitor. {ECO:0000250}.;
Intolerance Scores
- loftool
- 0.503
- rvis_EVS
- -0.08
- rvis_percentile_EVS
- 47.79
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.180
- ghis
- 0.636
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.178
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- activation of immune response;negative regulation of endopeptidase activity
- Cellular component
- extracellular space
- Molecular function
- serine-type endopeptidase inhibitor activity